Literature DB >> 2576319

The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.

H Y Meltzer, S Matsubara, J C Lee.   

Abstract

Atypical antipsychotic drugs such as clozapine, fluperlapine, and melperone produce weak catalepsy in rodents, and minimal extrapyramidal symptoms and serum prolactin elevations in humans, compared to typical antipsychotic drugs such as haloperidol. The biological basis for these differences has been attributed to relatively weak blockade at D2 dopamine (DA) receptors, various effects at D1 receptors, or potent serotonin2 (5-HT2) antagonism, although other possibilities exist. To clarify the relative importance of actions at D1, D2, and 5-HT2 receptors for identification of candidate typical and atypical drugs, we determined the negative log of the Ki (pKi) value of 21 typical and 17 atypical antipsychotic drugs for the striatal D1 and D2 and frontal cortex 5-HT2 receptors of rodent brain. Cluster analysis identified that the 5-HT2/D2 ratio was the most successful means of utilizing this data to classify typical and atypical antipsychotic drugs correctly. A 92 percent accuracy was achieved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576319

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  76 in total

1.  Introduction. Ziprasidone appears to offer important therapeutic and tolerability advantages over conventional, and some novel, antipsychotics.

Authors:  R Tandon
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

Review 2.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 3.  Managing antipsychotic-induced parkinsonism.

Authors:  D C Mamo; R A Sweet; M S Keshavan
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 4.  Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors:  Gary Remington
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

5.  Effect of clozapine on interval timing and working memory for time in the peak-interval procedure with gaps.

Authors:  Catalin V Buhusi; Warren H Meck
Journal:  Behav Processes       Date:  2006-10-14       Impact factor: 1.777

Review 6.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Ziprasidone therapy in elderly patients with psychotic mood disorders and Parkinson's disease.

Authors:  Alan L Berkowitz
Journal:  Psychiatry (Edgmont)       Date:  2006-11

8.  Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

Authors:  E L Gardner; L S Walker; W Paredes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 9.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

10.  Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.

Authors:  Arzu Gunes; Marja-Liisa Dahl; Edoardo Spina; Maria Gabriella Scordo
Journal:  Eur J Clin Pharmacol       Date:  2008-01-18       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.